Julius Axelrod Prize

Supported by Eli Lilly & Co.

Background
The Julius Axelrod Prize was established to honor a scientist with distinguished achievements in the broad field of neuropharmacology or a related area and exemplary efforts in mentoring young scientists. The prize, which includes $25,000, is presented each year at the Society's annual meeting. The recipient is invited to speak at a symposium organized by three institutes of the National Institutes of Health - the National Institute of Mental Health, the National Institute on Drug Abuse, and the National Institute of Neurological Disorders and Stroke - prior to SfN's annual meeting.

Eligibility
Nominations must be made or endorsed by a SfN member. In case the nominator is not an SfN member, the nomination package must include a letter of endorsement from a current Society member. Nominees do not have to be SfN members. 

Due to potential conflicts of interest, members of the Julius Axelrod Prize Selection Committee cannot serve as nominators. Self-nomination is not permitted.

Application Information
Please submit the following materials to awards@sfn.org prior to the deadline in order to be considered. 

• One nomination letter of not more than 750 words describing the nominee's significant scientific contributions and mentorship activities.
• A curriculum vitae to be a total of 2 pages that does not include publications, abstracts, grant support, or lectures.
• A list of 12 of the most important publications authored or co-authored by the nominee.
• A list of 5 scientists trained by the nominee and their current positions.

Past Recipients

• Michael Greenberg, PhD (2009)
• Leslie Iversen, PhD (2008)
• Richard Huganir, PhD and David Julius, PhD (2007)